M. L. Z. Dagli

From comparative oncology to AI-enabled precision medicine: translational biomodels for triple-negative breast cancer

Triple-negative breast cancer (TNBC), defined by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression or amplification, comprises a biologically heterogeneous group of tumors with aggressive clinical behavior and limited biomarker-guided treatment options. Alt...